Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results

Eurosurveillance

Volumn 21, Issue 13, 2016, Pages

  Pebody, Richard ^a   Warburton, F ^a   Ellis, J ^a   Andrews, N ^a   Potts, A ^b   Cottrell, S ^c   Johnston, J ^d   Reynolds, A ^b   Gunson, R ^e   Thompson, C ^a   Galiano, M ^a   Robertson, C ^f   Mullett, D ^g   Gallagher, N ^d   Sinnathamby, M ^a   Yonova, I ^g,h   Moore, C ^c   McMenamin, J ^b   de Lusignan, S ^g,h   Zambon, M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c PUBLIC HEALTH WALES   (United Kingdom)

^d PUBLIC HEALTH AGENCY   (United Kingdom)

^e West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^f UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^g UNIVERSITY OF SURREY   (United Kingdom)

^h ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SURVEILLANCE; FEMALE; FEVER; GENERAL PRACTITIONER; HEMAGGLUTINATION INHIBITION; HUMAN; INFANT; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; NONHUMAN; NOSE SMEAR; PRIMARY MEDICAL CARE; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SENTINEL SURVEILLANCE; UNITED KINGDOM; GENETICS; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; LABORATORY; PANDEMICS; PHYLOGENY; PRIMARY HEALTH CARE; SEASON; VACCINATION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LABORATORIES; MALE; MIDDLE AGED; PANDEMICS; PHYLOGENY; PRIMARY HEALTH CARE; SEASONS; SENTINEL SURVEILLANCE; UNITED KINGDOM; VACCINATION; YOUNG ADULT;

EID: 84962839020     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.13.30179     Document Type: Article

References (15)

1. Hakin B, Cosford P, Harvey F. The flu immunisation programme 2013/14– extension to children. London: Department of Health; 26 Jul 2013. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225360/Children_s_flu_letter_2013.pdf
2. Public Health England (PHE). PHE weekly national influenza report. Summary of UK surveillance of influenza and other seasonal respiratory illnesses 17 March 2016 – Week 11 report (up to week 10 data). London: PHE; 17 Mar 2016. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/508660/Weekly_report_current_wk_11_17Mar2016.pdf
3. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062-7. DOI:10.1136/jech.2009.093450 PMID: 19910645
4. Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill. 2014;19(27): 20851. DOI: 10.2807/1560-7917.ES2014.19.27.20851 PMID: 25033051
5. Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill. 2009;14(22):19230. PMID: 19497254
6. Gunson R, Maclean A, Davies E, Bennett S, Miller R, Carman WF. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods. 2010;163(2):258-61. DOI: 10.1016/j.jviromet.2009.10.006 PMID:19854220
7. Galiano M, Agapow P-M, Thompson C, Platt S, Underwood A, Ellis J, et al. Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS One. 2011;6(8):e23779. DOI:10.1371/journal.pone.0023779 PMID: 21887318
8. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol. 2003;77(15):8418-25. DOI: 10.1128/JVI.77.15.8418-8425.2003 PMID: 12857911
9. Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. 291-313.
10. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725-9. DOI: 10.1093/molbev/mst197 PMID:24132122
11. European Centre for Disease Prevention and Control (ECDC). Seasonal influenza 2015–16 in the EU/EEA countries. Stockholm: ECDC; 2016. Available from: http://ecdc.europa.eu/en/publications/Publications/seasonal-influenza-riskassessment-2015-2016.pdf
12. Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill. 2011;16(6):19791.PMID: 21329644
13. Kissling E, Valenciano M. Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. Euro Surveill. 2016;21(6):30134. DOI: 10.2807/1560-7917.ES.2016.21.6.30134 PMID: 26898240
14. Chambers C, Skowronski D, Sabaiduc S, Winter A, Dickinson J, De Serres G, et al. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro Surveill. 2016;21(11):30168. DOI:10.2807/1560-7917.ES.2016.21.11.30168
15. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2016-17 northern hemisphere influenza season. Geneva: WHO; 25 February 2016. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2016_17_north/en/